共 139 条
[1]
Brahm CG(2020)The current status of immune checkpoint inhibitors in neuro-oncology: a systematic review Cancers (Basel) 12 586-996
[2]
van Linde ME(2021)Clinical trials using oncolytic viral therapy to treat adult glioblastoma: a progress report Neurosurgical Focus FOC 50 E3-389
[3]
Enting RH(2005)Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 987-865
[4]
Schuur M(2020)Survival after hypofractionation in glioblastoma: a systematic review and meta-analysis Radiat Oncol 15 145-816
[5]
Otten RHJ(2015)Hypofractionated versus standard radiation therapy with or without temozolomide for older glioblastoma patients Int J Radiat Oncol Biol Phys 92 384-351
[6]
Heymans MW(2018)Radiation, inflammation and the immune response in cancer Mamm Genome 29 843-453
[7]
Lu VM(2018)The intertwined fates of inflammation and coagulation in glioma Mamm Genome 29 806-20
[8]
Shah AH(2017)Serial changes in lymphocyte subsets in patients with newly diagnosed high grade astrocytomas treated with standard radiation and temozolomide J Neurooncol 135 343-8
[9]
Vallejo FA(2019)Radiotherapy, lymphopenia, and host immune capacity in glioblastoma: a potentially actionable toxicity associated with reduced efficacy of radiotherapy Neurosurgery 85 441-2265
[10]
Eichberg DG(2014)Immunocompetent murine models for the study of glioblastoma immunotherapy J Transl Med 12 107-e781